SmithKline Corporation – Trademark Portfolio

Entity Type: 98

SmithKline Corporation holds 70 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 57 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include DCP, PARNATE, TAGAMET, DEXEDRINE, and HEMOCCULT. The owner is based in Philadelphia, PA.